Wall Street Analysts Weigh In on CoStar Groups Growth Potential Kevin Warsh Faces FOMC Rift Over Rate Cuts as Inflation Pressures Persist Swatch Watch Launch Sparks Resale Frenzy With Prices Soaring Over 4700 Immersion Corporation IMMR Slides 122 Fear or Fundamentals 20260521 Potential IranUS MoU Could Include Oil Sanctions Waiver and Nuclear Talks Timeline Berkshire Hathaway Increases Alphabet Stake by 224 and Takes 26 Billion Position in Delta Air Lines Indian Rupee Stages Sharp Recovery as RBI Intervention Provides Strong Support SP 500 Edges Higher Led by Healthcare and Tech Communication Services Lags Micron Technology Shares Rise Following UBS Price Target Upgrade on AI Demand Optimism Paytm Block Deal Institutional Investors Lead Rs 964 Crore Stake Sale in One 97 Communications KBR Q1 2026 Earnings EPS Beat Fails to Lift Shares MGX Q1 2026 Earnings EPS Miss Reflects Increased RD Spending Amid Pipeline Progress OZKAP Q1 2026 Earnings Marginal EPS Miss Amid Stable Performance Personalis Inc PSNL Q1 2026 Earnings EPS Misses Estimates While Stock Rises 267 Barnes Noble Education Inc BNED Q4 2025 Earnings NarrowerThanExpected Loss Lifts Shares Amid Structural Challenges RLGT Q1 2026 Earnings EPS Surpasses Estimates with 659 Beat Comfort Systems FIX Holds Steady Near Resistance Consolidation Pattern Emerges TMobile US TMUS Holds Steady Near Resistance as Trading Volume Remains Moderate Mount Logan Capital Inc MLCI Slips 2 Testing Support Zone After Recent Rally Oxbridge Re Holdings OXBR Edges Higher Tests Key Resistance at 104 Vroom Inc VRM Faces Pressure as Shares Slide Over 6 Amazon Expands AI Shopping Platform to Retail Partners Signs Kate Spade CSV Q1 2026 Earnings Modest EPS Beat Amid Muted Market Response Biomea Fusion Shares Surge Over 6 as BMEA Tests Key Resistance Allegheny ATI Jumps 219 on Strong Momentum 20260520 Markets Raise Chances for a Fed Rate Hike Following Hot Inflation Report Theriva Biologics TOVX Dips 1 as Stock Hovers Near Key Support at 028 AI Energy and Infrastructure Trade Outperforms Nvidia Doubling Returns Zevra Therapeutics ZVRA Climbs 127 Resistance at 1085 in Focus 20260520 Avient AVNT Q1 2026 Results Exceed Forecasts Key Drivers Inside Ohio OVBC Q3 2025 Results Steady as Expected